Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct 16;8(10):e78475.
doi: 10.1371/journal.pone.0078475. eCollection 2013.

Estimated glomerular filtration rate, all-cause mortality and cardiovascular diseases incidence in a low risk population: the MATISS study

Affiliations

Estimated glomerular filtration rate, all-cause mortality and cardiovascular diseases incidence in a low risk population: the MATISS study

Chiara Donfrancesco et al. PLoS One. .

Erratum in

  • PLoS One. 2014;9(1). doi:10.1371/annotation/1f5e18af-4a68-4419-9f3f-7e8bff410b48

Abstract

Background: Chronic kidney disease (CKD) independently increases the risk of death and cardiovascular disease (CVD) in the general population. However, the relationship between estimated glomerular filtration rate (eGFR) and CVD/death risk in a general population at low risk of CVD has not been explored so far.

Design: Baseline and longitudinal data of 1465 men and 1459 women aged 35-74 years participating to the MATISS study, an Italian general population cohort, were used to evaluate the role of eGFR in the prediction of all-cause mortality and incident CVD.

Methods: Bio-bank stored sera were used to evaluate eGFR at baseline. Serum creatinine was measured on thawed samples by means of an IDMS-calibrated enzymatic method. eGFR was calculated by the CKD-EPI formula.

Results: At baseline, less than 2% of enrolled persons had eGFR < 60 mL/min/1.73 m(2) and more than 70% had a 10-year cardiovascular risk score < 10%. In people 60 or more years old, the first and the last eGFR quintiles (<90 and ≥109 mL/min/1.73 m(2), respectively) were associated to an increased risk for both all-cause mortality (hazard ratio 1.6, 95% confidence interval 1.2-2.1 and 4.3, 1.6-11.7, respectively) and incident CVD (1.6, 1.0-2.4 and 7.0, 2.2-22.9, respectively), even if adjusted for classical risk factors.

Conclusions: These findings strongly suggest that in an elderly, general population at low risk of CVD and low prevalence of reduced renal filtration, even a modest eGFR reduction is related to all-cause mortality and CVD incidence, underlying the potential benefit to this population of considering eGFR for their risk prediction.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Similar articles

Cited by

References

    1. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ et al. (2007) Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from Kidney Disease Improving Global Outcomes. Kidney Int; 72: 247–259. doi:10.1038/sj.ki.5002343. PubMed: 17568785. - DOI - PubMed
    1. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classifi cation, and stratification. Am J Kidney Dis 39: S1–266. doi:10.1053/ajkd.2002.30571. PubMed: 11904577. - DOI - PubMed
    1. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH (2004) Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164: 659–663. doi:10.1001/archinte.164.6.659. PubMed: 15037495. - DOI - PubMed
    1. Fried LF, Katz R, Sarnak MJ, Shlipak MG, Chaves PH et al. (2005) Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 16: 3728–3735. doi:10.1681/ASN.2005040384. PubMed: 16251239. - DOI - PubMed
    1. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z et al. (2012) European guidelines on cardiovascular disease prevention in clinical practice (Version 2012). Eur Heart J 33: 1635–1701. doi:10.1093/eurheartj/ehs092. PubMed: 22555213. - DOI - PubMed

Publication types